J

Researcher Profile

Junko Yamaguchi

🏛 1Daiichi Sankyo Co., Ltd., Tokyo, Japan.

2

Publications

1,272

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article Molecular Cancer Therapeutics Aug 19, 2021

Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells

Daisuke Okajima · Satoru Yasuda · Takanori Maejima · Tsuyoshi Karibe +19 more

10.1158/1535-7163.mct-21-0206 269 citations

Journal Article Clinical Cancer Research Oct 13, 2016

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1

Yusuke Ogitani · Tetsuo Aida · Katsunobu Hagihara · Junko Yamaguchi +12 more

10.1158/1078-0432.ccr-15-2822 1,003 citations

Publication Timeline

2021

1

2016

1

Frequent Co-Authors

Toshinori Agatsuma

Tomomichi Fujitani